Rate My Professor Glenn Furuta

Glenn Furuta, MD, is Professor of Pediatrics-Gastroenterology, Hepatology and Nutrition at the University of Colorado School of Medicine on the Anschutz Medical Campus. He holds the position of Section Head of Pediatric Gastroenterology and Hepatology at the Digestive Health Institute, Director of the Gastrointestinal Eosinophilic Diseases Program, and the La Cache Endowed Chair for GI Allergic and Immunologic Diseases at Children's Hospital Colorado. Furuta earned his BA from the University of Texas at Austin in 1982 and MD from Baylor College of Medicine in 1986. He completed internship, residency, and chief residency in pediatrics at Baylor College of Medicine from 1986 to 1990, followed by a fellowship in pediatric gastroenterology at Harvard Medical School/Children's Hospital Boston in 1993. From 1993 to 2006, he served as Instructor and later Assistant Professor of Pediatrics at Harvard Medical School, attending physician at Children's Hospital Boston and Massachusetts General Hospital, and research associate at Beth Israel and Brigham and Women's Hospitals. He joined the University of Colorado in 2007 as Associate Professor of Pediatrics, advancing to Professor in 2010 and Professor with Tenure in 2016, and assuming the role of Section Head in 2023.

Furuta's research specializations include mechanisms of inflammation in eosinophilic gastrointestinal diseases (EGIDs), novel methods such as the string test to detect gastrointestinal inflammation, clinical features of EGIDs, and clinical outcome metrics. He co-founded EnteroTrack to advance non-invasive monitoring for eosinophilic esophagitis (EoE). His influence in the field is evident through leadership of a multidisciplinary clinic that serves as an international model for EGID care, contributions to guidelines, and over 200 publications. Key publications include 'ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis' (Dellon et al., Am J Gastroenterol, 2025), 'Diagnosing eosinophilic esophagitis in pediatric patients' (Furuta et al., Expert Rev Gastroenterol Hepatol, 2025), and 'Eosinophilic esophagitis, the newest esophageal inflammatory disease' (Furuta et al., Nat Rev Gastroenterol Hepatol, 2009). Major awards encompass the Shwachman Lifetime Achievement Award from the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (2021), Career Teaching Scholar Award from the Department of Pediatrics (2022), Research Mentor Award (2025), and multiple Patient Family Experience Awards from Healthgrades (2017-2018).